Dual-phase creatine sachet for rapid high-dose delivery
Innovative creatine delivery system using self-emulsifying technology to enhance solubility and absorption. Offers significant improvement in bioavailability and user experience. Ideal for sports nutrition markets.
Overview
The dual-phase creatine sachet is an innovative solution designed to enhance the bioavailability of creatine by addressing common solubility and absorption challenges. Using a self-emulsifying delivery system (SEDS), this product allows for rapid high-dose creatine delivery in a consumer-friendly format. The technology enables the formation of a fine oil-in-water micro or nanoemulsion upon ingestion, optimizing creatine dispersion and absorption in the gastrointestinal tract. This novel system not only improves dissolution kinetics but also maintains physical stability, offering an improved user experience and potential for co-delivery of other bioactives.
Technical specifications
- Self-Emulsifying Delivery System (SEDS): Utilizes spontaneous emulsification to enhance creatine solubility and absorption.
- High-Dose Delivery: Each sachet delivers ≥5g of creatine, overcoming traditional solubility barriers.
- Micro/Nanoemulsion Formation: Droplet sizes under 200 nm enhance dispersion and absorption.
- GRAS Excipients: Uses generally recognized as safe (GRAS) materials to ensure consumer safety.
- Scalable Manufacturing: Employs spray-drying technology for conversion to solid sachets, proven across the food industry.
Technology readiness level
Currently at Technology Readiness Level 3, the dual-phase creatine sachet is in the early stages of development with ongoing formulation and validation processes. Future phases include stability studies, bioavailability assessments, and regulatory preparation, positioning it for further development and commercialization.
About Dublin City University
Dublin City University is a research‑intensive public university in Ireland with an applied, collaborative character. Industry engages through a co‑op program that places students within companies, contract research with faculty experts, and a research and enterprise campus that co‑locates startups and corporate R&D alongside university labs. Companies can access shared facilities, prototyping resources, and tailored training, supported by experienced business engagement and sponsored‑research staff. Research is backed by competitive funding from Science Foundation Ireland, Enterprise Ireland, the Health Research Board, the Irish Research Council, and European programs such as Horizon Europe. A dedicated technology transfer office advances IP strategy, licensing, and spin‑out creation, complemented by on‑campus incubation and accelerator supports.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.